NFKB1 and endometrial cancer: Proteasome inhibition has recently been shown to increase NF-κB-mediated transcription instead of inhibiting it in endometrial cancer cells, with an increase in nuclear NF-κB and NF-κB/target gene promoter complex formation [35].